Feature

Algorithm could help leverage data for pediatric oncology research

September 27, 2019
Investigators have developed an algorithm that appeared to accurately identify children with leukemia and lymphoma who would be appropriate for…
Cover Story

Growing incidence of Merkel cell carcinoma draws researchers’ attention

HemOnc Today, September 25, 2019
A dramatic increase in the rate of Merkel cell carcinoma has attracted new attention to this rare and aggressive skin cancer. Incidence of the…
Point/Counter

Is neoadjuvant immunotherapy the best treatment approach for regionally advanced Merkel cell carcinoma?

HemOnc Today, September 25, 2019
POINT Checkpoint inhibitors — specifically avelumab and pembrolizumab — have revolutionized the management of unresectable metastatic Merkel…
Feature

Neoadjuvant therapy may alter biliary microbiome in patients with pancreatic cancer

September 24, 2019
Patients with pancreatic cancer who received neoadjuvant therapy before pancreatoduodenectomy exhibited biliary microbiome alterations, according to…
Feature

Common cold virus could transform bladder cancer treatment

September 23, 2019
A novel therapeutic approach that involves the oncolytic virus coxsackievirus showed potential among a small cohort of patients with…
Feature

Seattle Cancer Care Alliance opens its doors to share its cellular therapy experience

September 18, 2019
The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular…
Feature

CAR T-cell therapy has some patients crowdfunding to cover costs

September 13, 2019
Aletta Weiss plans to undergo chimeric antigen receptor T-cell treatment for relapsed large B-cell lymphoma, and she’s turning to GoFundMe for…
Molecular Oncology

Risk, phenotypes, therapeutics and resistance

HemOnc Today, September 10, 2019
Wafik S. El-Deiry, MD, PhD, FACP
With the explosion of knowledge in molecular oncology, advances are being reported almost daily in the scientific and clinical literature. Here are…
Advanced Practice

APPs can serve as ‘advocate, coordinator’ for patients with chronic GVHD

HemOnc Today, September 10, 2019
Linda M. Perry, MS, PA-C
Chronic graft-versus-host disease can be a debilitating and even life-threatening complication of allogeneic hematopoietic stem cell transplantation…

Clinical trial participation studies show possible survival benefit, misconceptions of patient concerns

September 4, 2019
Participation in therapeutic drug trials appeared associated with longer OS among patients with non-small cell lung cancer, according to results of a…